1,712 results match your criteria Giornale italiano di cardiologia 2006[Journal]


[When a purely observational approach does not provide reliable evidence].

G Ital Cardiol (Rome) 2018 Dec;19(12):727-728

Centro Studi ANMCO, Fondazione per il Tuo cuore - HCF onlus, Firenze.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30258DOI Listing
December 2018

[Intravascular ultrasound-guided antegrade recanalization of a complex chronic total occlusion of the left anterior descending coronary artery: a case report].

G Ital Cardiol (Rome) 2018 Dec;19(12):724-726

U.O.C. Cardiologia Interventistica-UTIC, Ospedale Santo Spirito, Pescara.

Patients with coronary chronic total occlusion (CTO) if symptomatic for angina or with extensive inducible ischemia at provocative tests may be revascularized percutaneously or surgically. Percutaneous revascularization can be performed by antegrade or retrograde approach. In our case, in the presence of a long CTO of the left anterior descending coronary artery, the antegrade approach was chosen using an intravascular ultrasound (IVUS) catheter positioned in a secondary branch, to accurately identify the proximal lesion cap. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30257DOI Listing
December 2018
2 Reads

[Regional network for ST-elevation myocardial infarction in Italy: from development to management].

G Ital Cardiol (Rome) 2018 Dec;19(12):721-723

U.O.C. Cardiologia, Ospedale Maggiore, Bologna.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30256DOI Listing
December 2018
1 Read

[The second multicenter observational registry on the management of acute ST-elevation myocardial infarction in the Veneto Region (VENERE 2)].

Authors:

G Ital Cardiol (Rome) 2018 Dec;19(12):714-720

Background: We sought to evaluate the epidemiology and the management of ST-elevation acute myocardial infarction (STEMI) in the Veneto Region (VENERE 2) in 2014, 10 years after a similar survey conducted in the early 2000s.

Methods: Between October 2014 and March 2015, all consecutive patients admitted to the Cardiology Divisions of the Veneto Region with STEMI were enrolled in an observational, prospective, multicenter register, called VENERE 2. The main diagnostic and therapeutic efficiency indicators were analyzed and compared with data from the previous VENERE study performed 10 years earlier. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30255DOI Listing
December 2018
2 Reads

[The coronary sinus Reducer: a new opportunity for refractory angina. Comparison between Italian experiences].

G Ital Cardiol (Rome) 2018 Dec;19(12):705-713

Divisione di Cardiologia Interventistica, Dipartimento Cardio-Toraco-Vascolare, Istituto Scientifico San Raffaele, Milano.

Refractory angina is a disabling condition that afflicts patients in whom we have no more strategy to improve their quality of life. This phenomenon has been increasing over the last years due to longer life expectancy, also resulting in a significant impact upon healthcare resources. The coronary sinus Reducer is a novel technology designed to improve the quality of life of these patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30254DOI Listing
December 2018
1 Read

[Usefulness, timing and modality of ECG stress testing after myocardial revascularization].

G Ital Cardiol (Rome) 2018 Dec;19(12):692-704

Istituto di Cardiologia, UniversitĂ  degli Studi, Pisa.

Myocardial revascularization in patients with stable ischemic heart disease aims at eliminating myocardial ischemia, in order to (i) relieve anginal symptoms; (ii) improve functional capacity; and, possibly, (iii) improve prognosis. Given that ischemic recurrences are relatively common in patients undergoing myocardial revascularization, an appropriate follow-up is needed as part of a secondary prevention program. Stress testing can be here useful to: (i) detect residual or recurrent ischemia/angina; (ii) define functional capacity in order to establish physical aerobic training individualized programs; (iii) stratify prognosis. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3027.30253DOI Listing
December 2018
4 Reads

[Clinical applications of cardiac magnetic resonance imaging: heart failure and cardiomyopathies].

G Ital Cardiol (Rome) 2018 Dec;19(12):679-691

Dipartimento Cardiovascolare, ASST Papa Giovanni XXIII, Bergamo.

Cardiac magnetic resonance (CMR) has proved to be a powerful tool in the assessment of several cardiac diseases, thanks to its capability to offer multiparametric morphologic and functional evaluation of the heart and great vessels, using neither ionizing radiations nor nephrotoxic contrast medium. The accuracy in quantification of cardiac volumes and ejection fraction (gold standard) together with native and post-contrast myocardial tissue characterization have made CMR an invaluable tool for the diagnosis, prognosis and therapeutic planning in patients with heart failure and cardiomyopathy. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3027.30252DOI Listing
December 2018
4 Reads

[Do not prescribe or defer treatment: when doing less could be better for the patient].

Authors:
Marco Bobbio

G Ital Cardiol (Rome) 2018 Dec;19(12):676-678

giĂ  Direttore S.C. Cardiologia, A.O. Santa Croce e Carle, Cuneo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30251DOI Listing
December 2018

[The CULPRIT-SHOCK trial].

G Ital Cardiol (Rome) 2018 Dec;19(12):672-675

U.O.C. Cardiologia, Ospedale G.B. Morgagni, Forlì - Fondazione Cardiologica "Myriam Zito Sacco", Forlì.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30250DOI Listing
December 2018
1 Read

[What's new in the 2018 ESC guidelines for the diagnosis and management of syncope?]

G Ital Cardiol (Rome) 2018 Dec;19(12):668-671

Dipartimento di Cardiologia, Centro Aritmologico, Ospedali del Tigullio, Lavagna (GE).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30249DOI Listing
December 2018
1 Read

[Journey around the heart in the movies of the last century: from Charlie Chaplin to the present day].

Authors:
Andrea Pozzati

G Ital Cardiol (Rome) 2018 Dec;19(12):664-667

U.O.S. Cardiologia, Ospedale Dossetti di Bazzano (BO), AUSL di Bologna.

Imagine a journey through the cinema's history to recover the figure of the doctor in the last century. At the same time, we have found that the progress of medicine has conditioned the stories told on the big screen. Cardiology has achieved a leading role at the cinema when technological innovations have begun to emerge, from the '60s onwards. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30248DOI Listing
December 2018
2 Reads

[Giornale Italiano di Cardiologia Supplements and the Editor's role].

G Ital Cardiol (Rome) 2018 Dec;19(12):661-663

Editor, Giornale Italiano di Cardiologia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30247DOI Listing
December 2018

In questo numero.

Authors:

G Ital Cardiol (Rome) 2018 Dec;19(12)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30246DOI Listing
December 2018

[The hybrid strategy for complete myocardial revascularization in the frail elderly patient].

G Ital Cardiol (Rome) 2018 Nov;19(11):33-38

U.O.C. Cardiologia, Ospedale Belcolle, Viterbo.

The hybrid strategy allows for a complete myocardial revascularization in patients with multivessel coronary artery disease and a high frailty index. These patients, due to their old age and multi-comorbidities, are evaluated with inadequate tools for their clinical complexity and destined to an incomplete revascularization for increased surgical or procedural risk. Hybrid revascularization enables to use the best techniques resulting from the surgical and percutaneous approach defining a tailored strategy for the patient. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3019.30160DOI Listing
November 2018
4 Reads

[Tips and tricks: how to do a good coronary angioplasty? Instructions for use].

G Ital Cardiol (Rome) 2018 Nov;19(11):22-32

UnitĂ  di Cardiologia interventistica, Ospedale San Raffaele, Milano.

Percutaneous coronary angioplasty celebrated its 40th anniversary and gained an established role thanks to its remarkable results. The progressive development of techniques and materials together with a better understanding about the pharmacological treatment of patients with coronary artery disease contributed to this success. Nowadays percutaneous treatments have become a valid alternative to coronary artery bypass graft surgery in many patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30159DOI Listing
November 2018
1 Read

[Coronary artery disease: when to withhold a decision and call in the Heart Team? Almost never].

G Ital Cardiol (Rome) 2018 Nov;19(11):18-21

Divisione di Cardiologia, Centro Alte SpecialitĂ  e Trapianti (CAST), Ospedale Policlinico Gaspare Rodolico, UniversitĂ  degli Studi, Catania.

The expansion of the options for the treatment of patients with stable multivessel coronary artery disease (CAD), including medical therapy or myocardial revascularization by a surgical or a percutaneous strategy, has raised the need to set the decision-making process to select the optimal therapy on a multidisciplinary approach. Indeed, this latter would potentially lead to identify the most appropriate strategy for a given patient in the most transparent, shared and comprehensive way as possible. The multidisciplinary approach has been widely encouraged in the cardiovascular field, where it has been defined as "Heart Team" (HT), a collegial system essentially including a cardiac surgeon, a clinical cardiologist and an interventionalist. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30158DOI Listing
November 2018
1 Read

[Coronary artery disease: when to withhold a decision and call in the Heart Team? Almost every time].

Authors:
Lucia Torracca

G Ital Cardiol (Rome) 2018 Nov;19(11):14-17

U.O. Cardiochirurgia, Humanitas Research Hospital, Rozzano (MI).

The multidisciplinary discussion is a well-established method, highly widespread in different medical disciplines, with documented optimal results. This practice, despite mandate by international guidelines, is not universally applied to guide treatment in coronary artery disease (CAD) patients. The literature provides data both on overtreatment or undertreatment in different patient subsets, clearly suggesting its strong need. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3019.30157DOI Listing
November 2018
1 Read

[Is angioplasty in patients with stable coronary artery disease only a placebo? Absolutely not].

G Ital Cardiol (Rome) 2018 Nov;19(11):12-13

SOD Interventistica Cardiologica Strutturale, AOU Careggi, Firenze.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30156DOI Listing
November 2018

[Revascularization in stable coronary artery disease: what does the future hold after the ORBITA trial?]

Authors:
Rasha Al-Lamee

G Ital Cardiol (Rome) 2018 Nov;19(11):10-11

Imperial College London, Londra, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30155DOI Listing
November 2018

[What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization?]

G Ital Cardiol (Rome) 2018 Nov;19(11):5-9

Klinik für Kardiologie und Angiologie II, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Germania.

A revised version of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) guidelines on myocardial revascularization has recently been published. These guidelines represent the third time that the ESC and EACTS have brought together cardiologists and cardiac surgeons in a joint Task Force to review the available evidence, with the mission of drafting balanced, patient-oriented, clinical practice guidelines on myocardial revascularization. During the last 4 years, a large body of evidence has become available and brought substantial changes to the guidelines. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30154DOI Listing
November 2018
2 Reads

[Presentation].

Authors:
Chiara Fraccaro

G Ital Cardiol (Rome) 2018 Nov;19(11):3-4

Deputy Editor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30153DOI Listing
November 2018

[Prof. Eligio Piccolo].

Authors:
Pietro Delise

G Ital Cardiol (Rome) 2018 Nov;19(11):658-659

U.O. Cardiologia Ospedale P. Pederzoli Peschiera del Garda (VR) e-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30114DOI Listing
November 2018

[Hypokinetic cardiac arrest and hypereosinophilia: a case of Kounis or Churg-Strauss syndrome?]

G Ital Cardiol (Rome) 2018 Nov;19(11):655-657

Cardiologia, Ospedale S. Maria della Misericordia, Perugia.

Ischemic heart disease can be caused by multiple factors. However, epidemiological studies have evidenced an association between hypereosinophilia and acute coronary syndrome, most frequently observed in the Kounis and Churg-Strauss syndromes. We here report the case of a 37-year-old man, who was admitted to our hospital for acute coronary syndrome, complicated by hypokinetic cardiac arrest with severe hypereosinophilia. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3012.30113DOI Listing
November 2018
2 Reads

[Inverse association between mortality and estimated functional capacity in hypertensive male outpatients with established coronary artery disease].

G Ital Cardiol (Rome) 2018 Nov;19(11):648-654

Centro Studi Biomedici Applicati allo Sport, UniversitĂ  degli Studi, Ferrara - Dipartimento SanitĂ  Pubblica, AUSL Ferrara.

Background: Exercise capacity has been inversely associated with the incidence and severity of hypertension and cardiovascular disease. Cardiopulmonary exercise testing (CPET) is the gold standard for the determination of exercise capacity (i.e. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30112DOI Listing
November 2018
1 Read

[Therapeutic strategies in elderly patients with acute coronary syndromes].

G Ital Cardiol (Rome) 2018 Nov;19(11):640-647

Dipartimento Cardiovascolare, Ospedale Alessandro Manzoni, Lecco.

Because of the aging of the population, the proportion of elderly patients admitted to the coronary care unit for an acute coronary syndrome (ACS) is increasing. Until a decade ago, treatment of elderly patients was based on poor scientific evidence, as older patients were commonly excluded from randomized controlled trials. In the last years, real-world registries and randomized controlled trials specifically addressing the older population have been published and provided clear evidence. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3012.30111DOI Listing
November 2018
4 Reads

[Bleeding risk in patients with acute coronary syndromes treated with antiplatelet agents: incidence, prognosis and clinical evaluation. From research to clinical practice].

G Ital Cardiol (Rome) 2018 Nov;19(11):628-639

S.C. Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia.

Dual antiplatelet therapy (DAPT) including aspirin and a P2Y12 inhibitor is the cornerstone for the treatment of patients with acute coronary syndrome (ACS). The introduction of more potent drugs significantly reduced ischemic events, but with an associated increased risk of bleeding. Although appropriate estimation of bleeding risk by comparing the single drugs is challenging, mainly because of differences in definitions, it has been consistently shown that bleeding events are associated with an adverse outcome, both at short and long-term follow-up. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3012.30110DOI Listing
November 2018
4 Reads

[Influenza infection and risk of myocardial infarction: the protective effect of influenza vaccination. One more reason to vaccinate].

G Ital Cardiol (Rome) 2018 Nov;19(11):620-627

U.O. Cardiologia, Ospedale Maggiore, Bologna.

Influenza infection, although considered a relatively benign pathology, is associated with a high number of hospital admissions and significant mortality, especially for the most vulnerable subjects. There is a great deal of evidence regarding the existence of an association between influenza and occurrence of cardiovascular events. Influenza vaccination by reducing the transmission of infection aims to reduce its complications, including cardiovascular events. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3012.30109DOI Listing
November 2018
4 Reads

[What are the main novelties in the recent US and European guidelines for the management of hypertension?]

G Ital Cardiol (Rome) 2018 Nov;19(11):611-619

Dipartimento di Medicina, UniversitĂ  degli Studi, Perugia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30108DOI Listing
November 2018
1 Read

[Heart transplantation: from the pioneering era to future prospects].

G Ital Cardiol (Rome) 2018 Nov;19(11):606-610

U.O.C. Cardiochirurgia e Centro Trapianti di Cuore, Ospedale San Camillo-Forlanini, Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30107DOI Listing
November 2018
1 Read

[70th Anniversary of the Framingham Heart Study. Cardiovascular epidemiology from the past to the future].

G Ital Cardiol (Rome) 2018 Nov;19(11):601-605

Dipartimento Malattie Cardiovascolari, Dismetaboliche e dell'Invecchiamento, Istituto Superiore di SanitĂ , Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30106DOI Listing
November 2018

In questo numero.

Authors:

G Ital Cardiol (Rome) 2018 Nov;19(11)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30105DOI Listing
November 2018

[Treatment adherence in cardiovascular prevention].

G Ital Cardiol (Rome) 2018 Oct;19(10):41-56

U.O. Cardiologia Riabilitativa, Dipartimento di Cardioangiologia, Istituti Clinici Scientifici Maugeri, IRCCS di Pavia.

Treatment adherence is a key element for (i) improving prognosis in cardiovascular and/or high-risk patients, (ii) reducing the burden of morbidity and mortality associated with cardiovascular disease at a population level, and (iii) decreasing costs due to rehospitalizations.Promotion of adherence should embrace all pharmacological and non-pharmacological interventions in cardiovascular prevention, including lifestyle and behavioral changes. In this perspective, cardiac prevention and rehabilitation programs are the most appropriate and cost-effective setting for delivering structured and multi-component interventions on patient's adherence. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3001.30011DOI Listing
October 2018
7 Reads

[Cardiac rehabilitation "3.0": from the acute to the chronic stage. A position paper from the Italian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)].

G Ital Cardiol (Rome) 2018 Oct;19(10):3-40

U.O.C. Cardiologia e Riabilitazione Cardiologica, A.O. San Giovanni-Addolorata, Roma.

Cardiac rehabilitation (CR) represents a cardiology subspecialty that is devoted to the care of cardiac patients, early and long term after an acute event. CR aims at improving both quality of life and prognosis through risk and prognostic stratification, clinical stabilization and optimization of therapy, management of comorbidities, treatment of disability, and the provision of sustained long-term preventive and rehabilitative services.The mission of CR has changed over time. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3001.30010DOI Listing
October 2018
9 Reads

[Presentation].

G Ital Cardiol (Rome) 2018 Oct;19(10)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3001.30009DOI Listing
October 2018

[Edoxaban in patients with atrial fibrillation and cancer].

G Ital Cardiol (Rome) 2018 Sep;19(9):13-19

U.O.C. Cardiologia, Ospedale Maggiore, Bologna.

Advances in cancer therapy have led to a significant improvement of survival in most types of malignancies over the past few decades. As a result, there is a growing population of cancer survivors, expected to reach 18 million people in 2030 in the US and a similar number in Europe. Interestingly, cancer survivor studies have shown that although about half of these patients eventually die of cancer, one third of them actually die of cardiovascular disease. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2989.29923DOI Listing
September 2018
1 Read

[Treatment of cancer-associated venous thromboembolism].

G Ital Cardiol (Rome) 2018 Sep;19(9):7-12

Dipartimento di Medicina e Scienze dell'Invecchiamento, UniversitĂ  degli Studi "G. d'Annunzio", Chieti.

Most clinical practice guidelines recommend low molecular weight heparin for the treatment of venous thromboembolism (VTE) in cancer patients. In the Hokusai VTE Cancer study, 1050 patients with cancer and acute VTE were randomized to oral edoxaban or subcutaneous dalteparin for at least 6 months and up to 12 months. Edoxaban was non-inferior to dalteparin with respect to the composite outcome of recurrent VTE and major bleeding. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2989.29922DOI Listing
September 2018
13 Reads

[Venous thromboembolism and atrial fibrillation in patients with cancer].

G Ital Cardiol (Rome) 2018 Sep;19(9):3-6

U.O.C. Cardiologia, Ospedale Maggiore, Bologna.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/2989.29921DOI Listing
September 2018

[Appropriateness criteria for the management of anticoagulant therapy in complex patients with atrial fibrillation. The opinion of a group of expert Italian cardiologists].

G Ital Cardiol (Rome) 2018 Oct;19(10):591-600

S.C. Cardiologia, AOU Policlinico, Modena.

Atrial fibrillation (AF) is a common arrhythmia often associated with high thromboembolic risk. The purpose of this position paper is to provide clinicians with recommendations useful in managing some important issues regarding the use of anticoagulant therapy in patients with AF in particularly complex clinical situations.The RAND/UCLA appropriateness method, validated to combine the best available scientific evidence with the collective judgment of experts, was used to assess the judgment of an expert panel of cardiologists. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2978.29844DOI Listing
October 2018
3 Reads

[ANMCO position paper on sacubitril/valsartan in the management of patients with heart failure].

G Ital Cardiol (Rome) 2018 Oct;19(10):568-590

U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione "Garibaldi", Catania.

Sacubitril/valsartan, the first-in-class angiotensin receptor neprilysin inhibitor (ARNI), is the first medication to demonstrate a mortality benefit in patients with chronic heart failure and reduced ejection fraction (HFrEF) since the early 2000s. Sacubitril/valsartan simultaneously suppresses renin-angiotensin-aldosterone system activation through blockade of angiotensin II type 1 receptors and enhances the activity of vasoactive peptides including natriuretic peptides, through inhibition of neprilysin, the enzyme responsible for their degradation. In the landmark PARADIGM-HF trial, patients with HFrEF treated with sacubitril/valsartan had a 20% reduction in the primary composite endpoint of cardiovascular death or heart failure hospitalization, a 20% lower risk of cardiovascular death, a 21% to 20% lower risk of a first heart failure hospitalization, and a 16% to 20% lower risk of death from any cause, compared with subjects allocated to enalapril (all p<0. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2978.29843DOI Listing
October 2018
16 Reads

[Percutaneous closure of a very large atrial septal defect: a case report and literature review].

G Ital Cardiol (Rome) 2018 Oct;19(10):563-567

Dipartimento di Scienze Cardiache, Toraciche e Vascolari, UniversitĂ  degli Studi, Padova.

Percutaneous transcatheter closure of ostium secundum atrial septal defects (ASD) is the gold-standard treatment, because of a comparable efficacy and less complications than heart surgery. Nevertheless, percutaneous treatment of very large ASD is still considered a challenging procedure and is discouraged for diameters larger than 38 mm, especially when atrial septal rims are absent. These patients are characterized by more frequent complications when a percutaneous approach is attempted. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2978.29842DOI Listing
October 2018
1 Read

[Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome].

G Ital Cardiol (Rome) 2018 Oct;19(10):552-562

U.O.C. Cardiologia, P.O. San Filippo Neri, ASL Roma 1, Roma.

Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome is a difficult challenge because of the need of taking into consideration three different issues: the cardiac ischemic risk related to coronary artery disease and its treatment with angioplasty and stenting; the thromboembolic risk associated with atrial fibrillation; and the hemorrhagic risk related to the combined use of antiplatelet therapy (with one or two agents) and oral anticoagulant therapy.Data from many trials and meta-analyses currently support a combination therapy with oral anticoagulants (vitamin K antagonists or direct oral anticoagulants) and antiplatelet agents (aspirin and clopidogrel in dual or single antiplatelet therapy).Recently completed and ongoing trials aim to tackle the still controversial issues of this therapy: the choice of the anticoagulant agent and its dosage; the choice of the antiplatelet agent; the use of single or dual antiplatelet therapy and its duration. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2978.29841DOI Listing
October 2018
1 Read

[Prevention of cardioembolic events after intracranial hemorrhage].

G Ital Cardiol (Rome) 2018 Oct;19(10):542-551

Divisione di Medicina Interna ad Indirizzo Metabolico e Riabilitativo, Dipartimento di Scienze Mediche Traslazionali, UniversitĂ  degli Studi "Federico II", Napoli.

In high thromboembolic risk patients who experienced hemorrhagic stroke, the prevention of cardioembolic events and recurrence of intracranial bleeding should be guaranteed. The consultant cardiologist should carefully identify the most appropriate therapeutic approach for these patients. Among patients with previous hemorrhagic stroke, only few restart oral anticoagulant therapy (OAT) after cerebral bleeding; however, as reported by some registries, it is likely that resuming OAT exerts a favorable effect on the combined outcome of ischemic stroke/systemic embolism/all-cause death. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2978.29840DOI Listing
October 2018
1 Read

[Which role today for intra-aortic balloon counterpulsation?]

G Ital Cardiol (Rome) 2018 Oct;19(10):533-541

S.C. Cardiologia, Ospedale S. Maria della Misericordia, Perugia.

Intra-aortic balloon pump (IABP) is a percutaneous assist device that is easy to implant, is associated with low complication rates and, therefore, is widely used. It is commonly applied by femoral access, although it can be used with axillary access. It reduces afterload and preload, with a slight increase in mean arterial pressure and coronary perfusion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/2978.29839DOI Listing
October 2018
7 Reads

In questo numero.

Authors:

G Ital Cardiol (Rome) 2018 Oct;19(10)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/2978.29838DOI Listing
October 2018

[Evaluation of adverse drug reactions associated with direct oral anticoagulants recorded in the Italian Pharmacovigilance Network database using a specifically developed risk index].

G Ital Cardiol (Rome) 2018 Oct;19(10):3-11

U.O.C. Nefrologia e Dialisi, Ospedale "Leopoldo Parodi Delfino", Colleferro (RM).

The introduction into clinical practice of direct oral anticoagulants (DOAC) has widened the scenario in the prevention and treatment of thromboembolism. However, the evaluation of the balance between the thrombotic and hemorrhagic risks is a critical issue in the choice of an oral anticoagulant agent. The availability of safety and efficacy data for each drug represents the basis to operate treatment choices. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2984.29850DOI Listing
October 2018
1 Read

[Prof. Fausto Rovelli].

G Ital Cardiol (Rome) 2018 Sep;19(9):530-531

U.O. Cardiologia Riabilitativa S. Maria Nascente-Fondazione Don Gnocchi, Milano.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/2951.29673DOI Listing
September 2018
1 Read

[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation].

Authors:
Giuseppe Tarantini Giovanni Esposito Giuseppe Musumeci Chiara Fraccaro Anna Franzone Battistina Castiglioni Alessio La Manna Ugo Limbruno Alfredo Marchese Ciro Mauro Stefano Rigattieri Fabio Tarantino Caterina Gandolfo Gennaro Santoro Roberto Violini Flavio Airoldi Remo Albiero Manrico Balbi Giorgio Baralis Antonio Luca Bartorelli Francesco Bedogni Alberto Benassi Andrea Berni Giulio Bonzani Alessandro Santo Bortone Giuseppe Braito Carlo Briguori Elvis Brscic Paolo Calabrò Ivan Calchera Maurizio Cappelli Bigazzi Francesco Caprioglio Fausto Castriota Carlo Cernetti Cinzia Cicala Paolo Cioffi Antonio Colombo Virgilio Colombo Gaetano Contegiacomo Alberto Cremonesi Maurizio D'Amico Mauro De Benedictis Alessandro De Leo Maurizio Di Biasi Domenico Di Girolamo Emilio Di Lorenzo Carlo Di Mario Marcello Dominici Federica Ettori Maurizio Ferrario Massimo Fioranelli Dionigi Fischetti Gabriele Gabrielli Arturo Giordano Pietro Giudice Cesare Greco Ciro Indolfi Ornella Leonzi Corrado Lettieri Bruno Loi Nicola Maddestra Niccolò Marchionni Cinzia Marrozzini Massimo Medda Bindo Missiroli Luigi My Jacopo Andrea Oreglia Cataldo Palmieri Paolo Pantaleo Saro Roberto Paparoni Guido Parodi Anna Sonia Petronio Luigi Piatti Emanuela Piccaluga Carlo Pierli Andrea Perkan Antonino Pitì Arnaldo Poli Angelo Bruno Ramondo Maurizio Alessandro Reale Bernhard Reimers Flavio Luciano Ribichini Roberta Rosso Salvatore Saccà Cosimo Sacra Andrea Santarelli Gennaro Sardella Gaetano Satullo Filippo Scalise Massimo Siviglia Leonardo Spedicato Amerigo Stabile Corrado Tamburino Tullio Nicola Maria Tesorio Salvatore Tolaro Fabrizio Tomai Carlo Trani Renato Valenti Orazio Valsecchi Giuseppe Valva Ferdinando Varbella Carlo Vigna Luigi Vignali Sergio Berti

G Ital Cardiol (Rome) 2018 Sep;19(9):519-529

Ospedale del Cuore, Fondazione CNR Toscana G. Monasterio, Pisa.

Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis and has become the standard of care for inoperable patients and the preferred therapy for those at increased surgical risk with peculiar clinical and anatomic features. Technology advances, growing experience and accumulating data prompted the update of the 2011 Italian Society of Interventional Cardiology (SICI-GISE) position paper on institutional and operator requirements to perform TAVI. The main objective of this document is to provide a guidance to assess the potential of institutions and operators to initiate and maintain an efficient TAVI program. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/2951.29672DOI Listing
September 2018
13 Reads

[Rescue thrombolytic therapy for the treatment of ST-elevation myocardial infarction after unsuccessful primary percutaneous coronary intervention in a patient with coronary artery aneurysm].

G Ital Cardiol (Rome) 2018 Sep;19(9):514-518

U.O. Cardiologia, Ospedale Morgagni-Pierantoni, Forlì - Unità di Ricerca Cardiovascolare, Fondazione Cardiologica Myriam Zito Sacco, Forlì.

The recommended treatment for ST-segment elevation myocardial infarction (STEMI) is primary percutaneous coronary intervention (pPCI). However, in a non-negligible proportion of patients, pPCI is ineffective and the cardiologist must face the decision of how to achieve optimal myocardial reperfusion. Although the possibility of a rescue fibrinolytic strategy has not been evaluated yet in this clinical setting, it is a viable alternative to emergency cardiac surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/2951.29671DOI Listing
September 2018
2 Reads